Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value ($000): $377,374 (100.0% shares, 0.0% debt)

Holdings (54)

RECEPTOS INC 5.4%
Value ($000) $20,397 Shares 478,800 Est. Cost $32.51 Unrealized
OMER OMEROS CORP 5.2%
Value ($000) $19,540 Shares 1,123,000 Est. Cost $12.47 Unrealized +1.2%
QUESTCOR PHARMACEUTICALS INC 4.9%
Value ($000) $18,498 Shares 200,000 Est. Cost $92.49 Unrealized
KARYOPHARM THERAPEUTICS INC 4.7%
Value ($000) $17,922 Shares 385,000 Est. Cost $33.09 Unrealized
DYAX CORP 4.6%
Value ($000) $17,280 Shares 1,800,000 Est. Cost $7.54 Unrealized
CELGENE CORP 4.6%
Value ($000) $17,176 Shares 200,000 Est. Cost $85.88 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 3.9%
Value ($000) $14,892 Shares 1,168,000 Est. Cost $9.67 Unrealized +0.6%
JAZZ JAZZ PHARMACEUTICALS PLC 3.9%
Value ($000) $14,701 Shares 100,000 Est. Cost $150.52 Unrealized -7.9%
PBYI PUMA BIOTECHNOLOGY INC 3.6%
Value ($000) $13,695 Shares 207,500 Est. Cost $60.82 Unrealized +16.9%
ARROWHEAD RESH CORP 3.4%
Value ($000) $12,879 Shares 900,000 Est. Cost $10.85 Unrealized
AKBA AKEBIA THERAPEUTICS INC 2.9%
Value ($000) $11,116 Shares 400,000 Est. Cost $24.08 Unrealized 0.0%
GALT GALECTIN THERAPEUTICS INC 2.9%
Value ($000) $11,048 Shares 800,000 Est. Cost $13.23 Unrealized -5.9%
TESARO INC 2.5%
Value ($000) $9,333 Shares 300,000 Est. Cost $28.24 Unrealized
HRTX HERON THERAPEUTICS INC 2.3%
Value ($000) $8,624 Shares 700,000 Est. Cost $11.95 Unrealized 0.0%
DXCM DEXCOM INC 2.1%
Value ($000) $7,932 Shares 200,000 Est. Cost $7.91 Unrealized +12.0%
SGMO SANGAMO BIOSCIENCES INC 2.0%
Value ($000) $7,635 Shares 500,000 Est. Cost $17.13 Unrealized -16.0%
MALLINCKRODT PUB LTD CO 1.9%
Value ($000) $7,202 Shares 90,000 Est. Cost $80.02 Unrealized
ACELRX PHARMACEUTICALS INC 1.9%
Value ($000) $7,175 Shares 700,000 Est. Cost $11.31 Unrealized
NOVAVAX INC 1.8%
Value ($000) $6,930 Shares 1,500,000 Est. Cost $4.95 Unrealized
ACCELERON PHARMA INC 1.8%
Value ($000) $6,794 Shares 200,000 Est. Cost $33.97 Unrealized
SRNE SORRENTO THERAPEUTICS INC 1.8%
Value ($000) $6,750 Shares 1,000,000 Est. Cost $10.01 Unrealized -24.7%
CHIMERIX INC 1.7%
Value ($000) $6,582 Shares 300,000 Est. Cost $19.16 Unrealized
PORTOLA PHARMACEUTICALS INC 1.5%
Value ($000) $5,836 Shares 200,000 Est. Cost $25.84 Unrealized
MRK MERCK & CO INC NEW 1.5%
Value ($000) $5,785 Shares 100,000 Est. Cost $35.76 Unrealized +6.2%
EGRX EAGLE PHARMACEUTICALS INC 1.5%
Value ($000) $5,732 Shares 400,000 Est. Cost $13.58 Unrealized -16.0%
VERSARTIS INC 1.5%
Value ($000) $5,608 Shares 200,000 Est. Cost $28.04 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL INC 1.4%
Value ($000) $5,387 Shares 120,000 Est. Cost $46.32 Unrealized -11.1%
APPLIED GENETIC TECHNOLOGIES 1.3%
Value ($000) $5,050 Shares 218,600 Est. Cost $23.10 Unrealized
ALKS ALKERMES PLC 1.3%
Value ($000) $5,033 Shares 100,000 Est. Cost $47.58 Unrealized -3.1%
ROCKWELL MED INC 1.3%
Value ($000) $4,796 Shares 400,000 Est. Cost $12.66 Unrealized
ARRAY BIOPHARMA INC 1.2%
Value ($000) $4,560 Shares 1,000,000 Est. Cost $5.01 Unrealized
PUMA BIOTECHNOLOGY INC 1.2%
Value ($000) $4,500 Shares 5,000 Est. Cost $900.00 Unrealized
NANOSTRING TECHNOLOGIES INC 1.2%
Value ($000) $4,485 Shares 300,000 Est. Cost $20.65 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 1.2%
Value ($000) $4,451 Shares 300,000 Est. Cost $14.11 Unrealized 0.0%
CHINA BIOLOGIC PRODS INC 1.2%
Value ($000) $4,447 Shares 100,000 Est. Cost $44.47 Unrealized
QUOTIENT LTD 1.1%
Value ($000) $4,180 Shares 500,000 Est. Cost $8.36 Unrealized
RECRO PHARMA INC 1.1%
Value ($000) $4,005 Shares 500,000 Est. Cost $7.32 Unrealized
GLYCOMIMETICS INC 1.1%
Value ($000) $3,981 Shares 472,300 Est. Cost $16.33 Unrealized
PTCT PTC THERAPEUTICS INC 1.0%
Value ($000) $3,921 Shares 150,000 Est. Cost $26.39 Unrealized -18.9%
GENVEC INC 0.9%
Value ($000) $3,416 Shares 1,329,300 Est. Cost $2.65 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 0.8%
Value ($000) $3,159 Shares 50,000 Est. Cost $59.65 Unrealized -0.4%
ALDER BIOPHARMACEUTICALS INC 0.8%
Value ($000) $3,011 Shares 150,000 Est. Cost $20.07 Unrealized
CLOVIS ONCOLOGY INC 0.8%
Value ($000) $2,899 Shares 70,000 Est. Cost $60.27 Unrealized
AGENUS INC 0.8%
Value ($000) $2,898 Shares 900,000 Est. Cost $3.17 Unrealized
AQUINOX PHARMACEUTICALS INC 0.7%
Value ($000) $2,829 Shares 300,000 Est. Cost $12.15 Unrealized
CERULEAN PHARMA INC 0.7%
Value ($000) $2,610 Shares 450,000 Est. Cost $5.80 Unrealized
AUSPEX PHARMACEUTICALS INC 0.6%
Value ($000) $2,227 Shares 100,000 Est. Cost $30.76 Unrealized
KINDRED BIOSCIENCES INC 0.5%
Value ($000) $1,864 Shares 100,000 Est. Cost $18.64 Unrealized
REGULUS THERAPEUTICS INC 0.4%
Value ($000) $1,608 Shares 200,000 Est. Cost $8.21 Unrealized
AGILE THERAPEUTICS INC 0.3%
Value ($000) $1,308 Shares 150,000 Est. Cost $8.72 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 0.3%
Value ($000) $1,130 Shares 50,000 Est. Cost $23.59 Unrealized -11.5%
CURIS INC 0.3%
Value ($000) $1,116 Shares 600,000 Est. Cost $1.86 Unrealized
SCYNEXIS INC 0.2%
Value ($000) $802 Shares 100,000 Est. Cost $8.02 Unrealized
CELSUS THERAPEUTICS PLC 0.2%
Value ($000) $639 Shares 103,000 Est. Cost $6.49 Unrealized